Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Olson

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 6, 2016
Design and optimization of tricyclic gamma-secretase modulatorsJianliang Shi, Dmitry Zuev, Li Xu, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2017
Design and synthesis of a novel series of (1'S,2R,4'S)-3H-4'-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,2'-bicyclo[2.2.2]octanes] with high affinity for the α7 neuronal nicotinic receptorJames Cook, F Christopher Zusi, Matthew D Hill, et al.
The Journal of Biological Chemistry|January 5, 2002
Identification and characterization of presenilin-independent Notch signalingBridget E Berechid, Magali Kitzmann, Daniel R Foltz, et al.
The Journal of Biological Chemistry|October 13, 2007
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacologyLawrence G Iben, Richard E Olson, Lynn A Balanda, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2010
5-arylamino-1,2,4-triazin-6(1H)-one CRF1 receptor antagonistsWilliam D Schmitz, Allison B Brenner, Joanne J Bronson, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 21, 2007
Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 miceMargi E Goldstein, Yang Cao, Tracey Fiedler, et al.
Nucleic Acid Therapeutics|February 15, 2022
Acute Neurotoxicity of Antisense Oligonucleotides After Intracerebroventricular Injection Into Mouse Brain Can Be Predicted from Sequence FeaturesPeter H Hagedorn, Jeffrey M Brown, Amy Easton, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligandsArgyrios G Arvanitis, Joseph T Rescinito, Charles R Arnold, et al.
European Journal of Pharmacology|July 11, 2017
Synergistic inhibition of Aβ production by combinations of γ-secretase modulatorsAlan S Robertson, Lawrence G Iben, Cong Wei, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2016
Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonistsMatthew D Hill, Haiquan Fang, Sivarao V Digavalli, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|February 6, 2016
Design and optimization of tricyclic gamma-secretase modulatorsJianliang Shi, Dmitry Zuev, Li Xu, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2017
Design and synthesis of a novel series of (1'S,2R,4'S)-3H-4'-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,2'-bicyclo[2.2.2]octanes] with high affinity for the α7 neuronal nicotinic receptorJames Cook, F Christopher Zusi, Matthew D Hill, et al.
The Journal of Biological Chemistry|January 5, 2002
Identification and characterization of presenilin-independent Notch signalingBridget E Berechid, Magali Kitzmann, Daniel R Foltz, et al.
The Journal of Biological Chemistry|October 13, 2007
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacologyLawrence G Iben, Richard E Olson, Lynn A Balanda, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2010
5-arylamino-1,2,4-triazin-6(1H)-one CRF1 receptor antagonistsWilliam D Schmitz, Allison B Brenner, Joanne J Bronson, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 21, 2007
Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 miceMargi E Goldstein, Yang Cao, Tracey Fiedler, et al.
Nucleic Acid Therapeutics|February 15, 2022
Acute Neurotoxicity of Antisense Oligonucleotides After Intracerebroventricular Injection Into Mouse Brain Can Be Predicted from Sequence FeaturesPeter H Hagedorn, Jeffrey M Brown, Amy Easton, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligandsArgyrios G Arvanitis, Joseph T Rescinito, Charles R Arnold, et al.
European Journal of Pharmacology|July 11, 2017
Synergistic inhibition of Aβ production by combinations of γ-secretase modulatorsAlan S Robertson, Lawrence G Iben, Cong Wei, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2016
Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonistsMatthew D Hill, Haiquan Fang, Sivarao V Digavalli, et al.
Pageof 6